Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Secura Bio Inc.
Headquarters: Las Vegas , NV, United States of America
Website: https://securabio.com/
Year Founded: 2019
Status: Private
BioCentury | Sep 24, 2022
Politics, Policy & Law
Sept. 23 Quick Takes: U.K.’s growth plan to support biotech
Plus FDA panel declines to back Copiktra and updates from AstraZeneca, Ionis and more
BioCentury | Sep 21, 2022
Deals
Sept. 21 Quick Takes: Germany’s Merck in deal with Nerviano for PARP1 inhibitor
Plus Celltrion gains rights to T cell engager from Abpro, and updates from Moat, Day One, Secura and more
BioCentury | Sep 3, 2022
Data Byte
September’s FDA advisory committee line-up
Three cancer therapies on the agenda, plus an ALS therapy and a live fecal microbiota
BioCentury | Jul 22, 2022
Regulation
ODAC to consider two drugs amid FDA skepticism
FDA says Pepaxto, Copiktra may cause higher risk of death, but EMA has recently endorsed both
BioCentury | Dec 1, 2021
Regulation
FDA cancels ODAC meeting on two accelerated approvals
Decision may be last stop on regulatory ride for Farydak and Marqibo
BioCentury | Sep 24, 2021
Product Development
Sept. 23 Quick Takes: $72M series A for stem cell newco Garuda
Plus: On deck at ODAC, GenEdit, Worg-Apitope, Reata, Tyvyt and more
Items per page:
1 - 7 of 7